MGRX - MANGOCEUTICALS, INC.


0.373
0.001   0.268%

Share volume: 12,107,786
Last Updated: 03-06-2026
Healthcare/Services – Health: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$0.37
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
41%
Profitability 43%
Dept financing 23%
Liquidity 15%
Performance 50%
Company vs Stock growth
vs
Performance
5 Days
-25.49%
1 Month
-1.58%
3 Months
-66.99%
6 Months
-84.26%
1 Year
-92.94%
2 Year
74.71%
Key data
Stock price
$0.37
P/E Ratio 
0.00
DAY RANGE
$0.34 - $0.37
EPS 
-$3.95
52 WEEK RANGE
$0.34 - $5.29
52 WEEK CHANGE
-$92.40
MARKET CAP 
23.073 M
YIELD 
N/A
SHARES OUTSTANDING 
13.907 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
-0.61
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,706,805
AVERAGE 30 VOLUME 
$18,849,203
Company detail
CEO: Jacob D. Cohen
Region: US
Website: www.mangorx.com
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

We plan to connect consumers to licensed healthcare professionals through our recently launched website at www.MangoRX.com for the provision of care via telehealth on our customer portal and plan to also provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. Our principal executive offices are located in Dallas, Texas.

Recent news